Research theme for competitive and other funds (1)：
2021 - 2023 機能性RNA解析に基づく治療抵抗性小児白血病に対する革新的治療標的の探索
Papers (15)：
Ming Sun, Yingying Cao, Reona Okada, Jeyshka M Reyes-González, Hannah G Stack, Haiying Qin, Nan Li, Charlie Seibert, Michael C Kelly, Eytan Ruppin, et al. Preclinical optimization of a GPC2-targeting CAR T-cell therapy for neuroblastoma. Journal for immunotherapy of cancer. 2023. 11. 1
Shunsuke Misono, Keiko Mizuno, Takayuki Suetsugu, Kengo Tanigawa, Nijiro Nohata, Akifumi Uchida, Hiroki Sanada, Reona Okada, Shogo Moriya, Hiromasa Inoue, et al. Molecular Signature of Small Cell Lung Cancer after Treatment Failure: The MCM Complex as Therapeutic Target. Cancers. 2021. 13. 6
Reona Okada, Yusuke Goto, Yasutaka Yamada, Mayuko Kato, Shunichi Asai, Shogo Moriya, Tomohiko Ichikawa, Naohiko Seki. Regulation of Oncogenic Targets by the Tumor-Suppressive miR-139 Duplex (miR-139-5p and miR-139-3p) in Renal Cell Carcinoma. Biomedicines. 2020. 8. 12
Yoshiaki Shinden, Tadahiro Hirashima, Nijiro Nohata, Hiroko Toda, Reona Okada, Shunichi Asai, Takako Tanaka, Yuto Hozaka, Takao Ohtsuka, Yuko Kijima, et al. Molecular pathogenesis of breast cancer: impact of miR-99a-5p and miR-99a-3p regulation on oncogenic genes. Journal of human genetics. 2020. 66. 5. 519-534
Takako Tanaka, Reona Okada, Yuto Hozaka, Masumi Wada, Shogo Moriya, Souichi Satake, Tetsuya Idichi, Hiroshi Kurahara, Takao Ohtsuka, Naohiko Seki. Molecular Pathogenesis of Pancreatic Ductal Adenocarcinoma: Impact of miR-30c-5p and miR-30c-2-3p Regulation on Oncogenic Genes. Cancers. 2020. 12. 10
日野 もえ子, 岡田 玲緒奈, 力石 浩志, 奥主 朋子, 下条 直樹. インヒビター保有血友病に対する周術期管理と早期免疫寛容療法・バイパス製剤定期投与併用療法(Perioperative management followed by ITI with prophylaxis for severe hemophilia A with inhibitors). 臨床血液. 2018. 59. 9. 1808-1808
